| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/11/2009 | CN101361815A Preparation method of catclaw buttercup total glycoside extract using macroporous resin and use thereof |
| 02/11/2009 | CN101361814A Traditional Chinese medicine formulation for treating tuberculosis disease |
| 02/11/2009 | CN101361810A Traditional Chinese medicine combination for treating virus lower respiratory tract infection and preparation method thereof |
| 02/11/2009 | CN101361808A Medicine for treating chronic hepatitis b |
| 02/11/2009 | CN101361792A Use of Mosla non-volatile extract in preparing anti-influenza medicine |
| 02/11/2009 | CN101361788A Traditional Chinese medicine formulation for treating measles |
| 02/11/2009 | CN101361765A Anti-coxsackie and anti-herpesvirus extract of selaginella tamariscina and extraction technique and formulation thereof |
| 02/11/2009 | CN101361753A Use of poly(styrene-alternate-sodium maleate) |
| 02/11/2009 | CN101361752A Use of polystyrol-poly(styrene-alternate-sodium maleate) |
| 02/11/2009 | CN101361744A Medicine composite containing nitrimidazine phosphate ester and use thereof |
| 02/11/2009 | CN101361743A Use of triazinetrione sulfones for combating coccidiosis |
| 02/11/2009 | CN101361739A Anti-bacteria agent for parenteral administration |
| 02/11/2009 | CN101361729A Thiamphenicol aminoacetate hydrochloride sterile freeze-drying preparation for injection and preparation method thereof |
| 02/11/2009 | CN101361723A Improved pharmaceutical compositions |
| 02/11/2009 | CN101361716A Porous microspheres and use thereof in preparing porous microspheres vaccine |
| 02/11/2009 | CN101361709A 0Long-acting enrofloxacin injection and preparation method thereof |
| 02/11/2009 | CN101361490A Calcium carbonate composite bactericidal agent and preparation method thereof |
| 02/11/2009 | CN100460503C Bacterin for pleuropneumonia actinobacillus serotype 1 double-gene deletion mutant without resistance marker |
| 02/11/2009 | CN100460417C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase |
| 02/11/2009 | CN100460415C Keto-lactones compound, purposes, preparation method and pharmaceutical composition thereof |
| 02/11/2009 | CN100460405C Polyacid compound for resisting penicillin streptococcus pneumoniae (PRSP) and preparing method thereof |
| 02/11/2009 | CN100460383C Compound and preparation method thereof and application in pharmacy |
| 02/11/2009 | CN100460366C Cimicifuga rhizome organic acid extraction method and novel uses |
| 02/11/2009 | CN100460014C Helicobacter pylori vaccine based on urease B subunit active segment and prepn process thereof |
| 02/11/2009 | CN100460013C Oral administration recombinant helicobacterpylori vaccine and preparing method thereof |
| 02/11/2009 | CN100460010C Chinese medicine composition for treating viral hepatitis |
| 02/11/2009 | CN100460006C Application of katsumada galangal seed or its substitute extracts or its inclusive compound in pharmacy |
| 02/11/2009 | CN100459997C Usage of composition of bitter tea and rhubarb horsetails |
| 02/11/2009 | CN100459979C Methionine vitamin B1 freeze dried composition and preparation method thereof |
| 02/11/2009 | CN100459920C Multifunctional disposable medicated toilet cushion and making process thereof |
| 02/10/2009 | US7488791 capable of stimulating the production of anti-HPV T CD4+ lymphocytes for vaccination against uterine of uterus cancer or as diagnostic reagent of HPV-specific T lymphocytes, in particular for assessing the immune condition of patients |
| 02/10/2009 | US7488759 Malic acid addition salts of terbinafine |
| 02/10/2009 | US7488726 Useful for treating or preventing a variety of antibiotic resistant microbial infections; for example, a 25-O-deacetyl-25-(2'',3''-dihydroxypropylcarbonoxy)-benzoxazinorifamycin |
| 02/10/2009 | US7488724 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors |
| 02/10/2009 | US7488712 Histone deacetylase inhibitors and methods for producing the same |
| 02/10/2009 | US7488497 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID |
| 02/10/2009 | US7488491 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 02/10/2009 | US7488487 Administering an auxotropic attenuation strain of Listeria which expresses an antigen; induction immunology response; anticancer agents |
| 02/10/2009 | US7488484 Multimeric protein fo treating and preventing viral infection; immunosuppressant |
| 02/10/2009 | CA2427199C Process for the production of ceftiofur sodium salt |
| 02/10/2009 | CA2389709C Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 02/10/2009 | CA2331368C Nucleic acid vaccines for prevention of flavivirus infection |
| 02/10/2009 | CA2292226C Chlorhexidine formulations, new chlorhexidine salts, solutions containing these and their use |
| 02/10/2009 | CA2255681C Composition and method for treating herpes simplex |
| 02/10/2009 | CA2208671C Substituted imides as tnf inhibitors |
| 02/10/2009 | CA2198743C Feline infectious peritonitis vaccine |
| 02/05/2009 | WO2009017795A1 Indazole compounds for treating inflammatory disorders, demyelinating disorders and cancers |
| 02/05/2009 | WO2009017456A1 Pharmaceutical composition suitable for adsorption to the cell surface of pathogenic microbes |
| 02/05/2009 | WO2009016425A1 Compounds of chemical synthesis with antirhinovirus activity |
| 02/05/2009 | WO2009016100A1 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections |
| 02/05/2009 | WO2009015892A1 Adefovir dipivoxil crystalline monohydrate form |
| 02/05/2009 | WO2009015541A1 Polyene diester antibiotics |
| 02/05/2009 | WO2009015446A2 Triazole derivatives as viral replication inhibitors |
| 02/05/2009 | WO2008150830A3 Metal complexes incorporated within biodegradable nanoparticles and their use |
| 02/05/2009 | WO2008140602A3 USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND α4β7 INTEGRIN |
| 02/05/2009 | WO2008130381A3 Polyglutamic acid compositions and their use as immunogens |
| 02/05/2009 | WO2008122534A3 Non-nucleoside reverse transcriptase inhibitors |
| 02/05/2009 | WO2003099808A8 Substituted heterocyclic compounds and methods of use |
| 02/05/2009 | US20090036666 Modified fluorinated nucleoside analogues |
| 02/05/2009 | US20090036533 Antibacterial agent comprising 7, 10-dihydroxy-8(e)-octadecenoic acid |
| 02/05/2009 | US20090036531 Method for treatment of onychomycosis |
| 02/05/2009 | US20090036513 Antiviral Drugs for Treatment of Arenavirus Infection |
| 02/05/2009 | US20090036506 5-Iodotetrazoles |
| 02/05/2009 | US20090036482 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 02/05/2009 | US20090036467 Alkylsulfonyl-substituted thiazolide compounds |
| 02/05/2009 | US20090036466 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication |
| 02/05/2009 | US20090036460 Crystalline pyridazine compound |
| 02/05/2009 | US20090036458 Endoparasiticidal topical compositions |
| 02/05/2009 | US20090036444 5-5-Membered fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
| 02/05/2009 | US20090036443 6-cyclohexyl-5-phenyl-4H-thieno[3,2-b]pyrrole-2-carboxylic acid, used for inhibiting hepatitis C virus polymerase or prevention and treatment of hepatitis C viral infections |
| 02/05/2009 | US20090036439 5-[(3',5'-dichloro-1,1'-biphenyl-3-yl)methylene]-3-(3,5-dichlorophenyl)-4-hydroxyfuran-2(5H)-one; bacterial cell wall biosynthesis via the Mur enzyme pathway; bactericides; paraciticides; nematocides; antibiotic-resistant diseases; agiculture; veterinary medicine |
| 02/05/2009 | US20090036433 Heterocyclic Compounds, their Preparation and their Use as Antibacterials |
| 02/05/2009 | US20090036419 Compounds useful as raf kinase inhibitors |
| 02/05/2009 | US20090036412 Methods and Compositions for Inhibition of Angiogenesis |
| 02/05/2009 | US20090036408 Compositions and methods for combination antiviral therapy |
| 02/05/2009 | US20090036406 Injection |
| 02/05/2009 | US20090036399 Nucleoside derivatives for treating hepatitis c virus infection |
| 02/05/2009 | US20090036389 Polymeric Micelle Formulations of Hydrophobic Compounds and Methods |
| 02/05/2009 | US20090036367 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine |
| 02/05/2009 | US20090036362 Angiogenesis Affecting Polypeptides, Proteins, and Composition, and Methods of Use Thereof |
| 02/05/2009 | US20090036360 Medicament containing activated antithrombin iii |
| 02/05/2009 | US20090036357 Azapeptide derivatives |
| 02/05/2009 | US20090036349 Methods and Compositions Related to Targeting Wounds, Regenerating Tissue, and Tumors |
| 02/05/2009 | US20090035402 Method for Extracting Plants of the Genus Pelargonium, Extract Produced According to Said Method, and Use Thereof |
| 02/05/2009 | US20090035342 Antimicrobial Devices and Compositions |
| 02/05/2009 | US20090035328 fHbp- AND LPXL1-BASED VESICLE VACCINES FOR BROAD SPECTRUM PROTECTION AGAINST DISEASES CAUSED BY NEISSERIA MENINGITIDIS |
| 02/05/2009 | US20090035327 Antibody Gene Transfer and Recombinant AAV Therefor |
| 02/05/2009 | US20090035326 Compositions with antigens adsorbed to calcium phosphate |
| 02/05/2009 | US20090035325 Canine influenza virus and related compositions and methods of use |
| 02/05/2009 | US20090035324 N-(2-(4-(4-fluoro(benzyl-d6)carbamoyl)-5-hydroxy-1-(methyl-d3)-6-oxo-1,6-dihydropyrimidin-2-yl)-(1,3-d6-propan)-2-yl)-5-(methyl-d3)-1,3,4-oxadiazole-2-carboxamide; use in methods of treating HIV infections |
| 02/05/2009 | US20090035305 Compositions and Methods for Treating Viral Infection |
| 02/05/2009 | US20090035296 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/05/2009 | US20090035294 Lipopolysaccharide fractions of vitreoscilla filiformis useful for stimulating the synthesis of anti-microbial peptides of the skin |
| 02/05/2009 | US20090035277 Hepatitis C Virus Nucleic Acid Vaccine |
| 02/05/2009 | US20090035276 Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 02/05/2009 | US20090035274 Treatment and/or prevention of cancer and/or arthritis |
| 02/05/2009 | US20090035273 Combination treatment method with interferon-tau |
| 02/05/2009 | US20090035272 Pyridazinonyl Macrocyclic Hepatitis C Serine Protease Inhibitors |
| 02/05/2009 | US20090035271 Tetrazolyl macrocyclic hepatitis c serine protease inhibitors |
| 02/05/2009 | US20090035268 Tetrazolyl acyclic hepatitis c serine protease inhibitors |